Modulation of in vitro anaphylaxis of guinea‐pig isolated tracheal segments by azelastine, inhibitors of arachidonic acid metabolism and selected antiallergic drugs

British Journal of Pharmacology

Volumn 87, Issue 2, 1986, Pages 443-448

  Chand, N ^a   Diamantis, W ^a   Sofia, R D ^a  

^a Wallace Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; 4 BROMOPHENACYL BROMIDE; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; AZELASTINE; CROMOGLYCATE DISODIUM; DIPHENHYDRAMINE; INDOMETACIN; KETOTIFEN; NORDIHYDROGUAIARETIC ACID; THEOPHYLLINE;

ANAPHYLAXIS; ANIMAL CELL; ARACHIDONIC ACID METABOLISM; DOSE RESPONSE; DRUG EFFICACY; DRUG INTERACTION; DRUG RESPONSE; GUINEA PIG; MUSCLE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SCHULTZ DALE REACTION; SMOOTH MUSCLE CONTRACTILITY; TRACHEA;

AIRWAY RESISTANCE; ANAPHYLAXIS; ANIMAL; ANTIGENS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; GUINEA PIGS; HYPERSENSITIVITY; IN VITRO; INDOMETHACIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHTHALAZINES; PYRIDAZINES; TRACHEA;

EID: 0023035014     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1986.tb10835.x     Document Type: Article

References (26)

1. Indomethacin enhances response of human bronchus to antigen
2. Azelastine inhibition of skin test reactivity in humans
3. Evidence for lipoxygenase pathway involvement in allergic tracheal contractions
4. FPL‐55712 — an antagonist of slow‐reacting substance of anaphylaxis (SRS‐A): A review
5. In vitro reversal of anaphylaxis in guinea pig lung strip by Compound FPL 55712 (a SRS‐A receptor antagonist)
6. Lipoxygenase pathway and hydroperoxy acids: Possible relevance to aspirin‐induced asthma and hyperirritability of airways in asthmatics
7. The Schultz‐Dale reaction. A review
8. Antagonism of leukotrienes, calcium and histamine by azelastine
9. Inhibition of leukotriene (SRS‐A)‐mediated allergic bronchospasm by azelastine, a novel, orally effective antiasthmatic drug
10. Effect of aerosolized azelastine on acute lung anaphylaxis in guinea pig sensitized by two different procedures
11. Inhibition of calcium ionophore (A23187)‐stimulated histamine release from rat peritoneal mast cells by azelatine: Implications for its mode of action
12. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes
13. Inhibition of IgE‐mediated allergic histamine release by azelastine and selected antiallergic drugs
14. The actions of 5‐HETE, 12‐HETE and 15‐HETE on tracheobronchial smooth muscles
15. 1 antagonist‐antiallergic agent
16. Inhibition of IgE‐mediated passive cutaneous anaphylaxis (PCA) by azelastine in rat
17. Dissociation of antiallergic (anti‐PCA) activity from the antihistaminic and antiserotonin activities of azelastine
18. Inhibition of azelastine of non‐allergic histamine release from rat peritoneal mast cells
19. Effects of selected antagonists on ovalbumin‐induced contraction of tracheal strip isolated from the actively sensitized guinea pig
20. Antiallergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro
21. Histamine protection and bronchodilation with azelastine, a new antiallergic compound
22. Multicenter trial of azelastine in allergic rhinitis
23. SRS‐A‐mediate bronchospasm by pharmacologic modification of lung anaphylaxis in vivo
24. Mediators of immediate hypersensitivity reactions and inflammation
25. Azelastine (AZEL) in the treatment of asthma
26. Pharmacological and toxicological properties of azelastine, a novel antiallergic agent